tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

MNPR Stock Latest News

Monopar Therapeutics price target raised to $37 from $9 at JonesResearch
The FlyMonopar Therapeutics price target raised to $37 from $9 at JonesResearch
7d ago
MNPR
Monopar Therapeutics price target raised to $22 from $6 at H.C. Wainwright
PremiumThe Fly
Monopar Therapeutics price target raised to $22 from $6 at H.C. Wainwright
16d ago
MNPR
Monopar Therapeutics reports Q3 EPS (37c), consensus (48c)
PremiumThe Fly
Monopar Therapeutics reports Q3 EPS (37c), consensus (48c)
19d ago
MNPR
Monopar Therapeutics Closes $19.2 Million Stock Offering
PremiumCompany Announcements
Monopar Therapeutics Closes $19.2 Million Stock Offering
27d ago
8K
MNPR
Monopar Therapeutics 1.16M share Spot Secondary priced at $16.25
PremiumThe Fly
Monopar Therapeutics 1.16M share Spot Secondary priced at $16.25
29d ago
MNPR
Monopar Therapeutics announces common stock offering, no amount given
PremiumThe FlyMonopar Therapeutics announces common stock offering, no amount given
29d ago
MNPR
Monopar Therapeutics Secures License for Wilson Disease Treatment
Premium
Company Announcements
Monopar Therapeutics Secures License for Wilson Disease Treatment
1M ago
8K
MNPR
Monopar Therapeutics enters agreement with Alexion, AstraZeneca Rare Disease
Premium
The Fly
Monopar Therapeutics enters agreement with Alexion, AstraZeneca Rare Disease
1M ago
MNPR
Monopar Therapeutics Unveils Promising Radiopharmaceutical Data
PremiumCompany Announcements
Monopar Therapeutics Unveils Promising Radiopharmaceutical Data
1M ago
8K
MNPR
Monopar Therapeutics presents data from radiopharma program based on MNPR-101
PremiumThe Fly
Monopar Therapeutics presents data from radiopharma program based on MNPR-101
1M ago
MNPR
Monopar Therapeutics Expands Portfolio with New Patent Filing
PremiumCompany Announcements
Monopar Therapeutics Expands Portfolio with New Patent Filing
1M ago
8K
MNPR
Monopar files provisional patent covering therapeutic radiopharmaceuticals
PremiumThe Fly
Monopar files provisional patent covering therapeutic radiopharmaceuticals
1M ago
MNPR
Monopar Therapeutics initiated with a Buy at Rodman & Renshaw
PremiumThe FlyMonopar Therapeutics initiated with a Buy at Rodman & Renshaw
2M ago
MNPR
Monopar Therapeutics initiates Phase 1a trial for MNPR-101-Lu
Premium
The Fly
Monopar Therapeutics initiates Phase 1a trial for MNPR-101-Lu
2M ago
MNPR
Monopar Therapeutics Launches Phase 1a uPAR-Targeted Cancer Trial
Premium
Company Announcements
Monopar Therapeutics Launches Phase 1a uPAR-Targeted Cancer Trial
2M ago
8K
MNPR
Monopar Therapeutics Reports Positive MNPR-101-Zr Trial Results
PremiumCompany Announcements
Monopar Therapeutics Reports Positive MNPR-101-Zr Trial Results
3M ago
8K
MNPR
Monopar Therapeutics announces early human clinical data for MNPR-101-Zr
PremiumThe Fly
Monopar Therapeutics announces early human clinical data for MNPR-101-Zr
3M ago
MNPR
Monopar Therapeutics regains compliance with Nasdaq minimum bid price rule
PremiumThe Fly
Monopar Therapeutics regains compliance with Nasdaq minimum bid price rule
3M ago
MNPR
Monopar Therapeutics receives HREC clearance in Australian for MNP-101L-u study
PremiumThe Fly
Monopar Therapeutics receives HREC clearance in Australian for MNP-101L-u study
3M ago
MNPR
Monopar Therapeutics target adjusted to $9 from $2 at JonesResearch
PremiumThe FlyMonopar Therapeutics target adjusted to $9 from $2 at JonesResearch
3M ago
MNPR
Monopar Therapeutics Begins Phase 1 Trial of MNPR-101-Zr
Premium
Company Announcements
Monopar Therapeutics Begins Phase 1 Trial of MNPR-101-Zr
3M ago
8K
MNPR
Monopar announces initial data for first patient dosed in trial of MNPR-101-Zr
Premium
The Fly
Monopar announces initial data for first patient dosed in trial of MNPR-101-Zr
3M ago
MNPR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >